{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T19:30:57Z","timestamp":1764963057633,"version":"3.46.0"},"reference-count":4,"publisher":"American Medical Association (AMA)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Intern Med"],"DOI":"10.1001\/archinte.160.15.2402","type":"journal-article","created":{"date-parts":[[2003,3,18]],"date-time":"2003-03-18T18:17:58Z","timestamp":1048011478000},"page":"2402","source":"Crossref","is-referenced-by-count":4,"title":["Geriatric Assessment and Anticoagulation in Elderly Patients With Chronic Atrial Fibrillation"],"prefix":"10.1001","volume":"160","author":[{"given":"Giuseppe","family":"Bellelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renzo","family":"Rozzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piera","family":"Barbisoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Sabatini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Trabucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2000,8,14]]},"reference":[{"key":"ref-ilt0814-10-1-1","unstructured":"TJBungardWAGhaliKKTeoFAMcAlisterRTTsuyukiWhy do patients with atrial fibrillation not receive warfarin?Arch Intern Med.20001604146"},{"key":"ref-ilt0814-10-1-2","unstructured":"The Stroke Prevention in Atrial Fibrillation InvestigatorsAdjusted-dose warfarin versus low-intensity fixed dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial.Lancet.1996348633638"},{"key":"ref-ilt0814-10-1-3","unstructured":"JLHalperinProspective identification of atrial fibrillation patients at low risk of stroke during treatment with aspirin: the SPAF-III Aspirin Low-Risk Cohort Study.Circulation.199796(suppl 1)1564"},{"key":"ref-ilt0814-10-1-4","unstructured":"The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation InvestigatorsPatients with nonvascualr fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study.JAMA.199827912731277"}],"container-title":["Archives of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/746455\/ilt0814.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T19:01:47Z","timestamp":1764961307000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/746455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8,14]]},"references-count":4,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2000,8,14]]}},"URL":"https:\/\/doi.org\/10.1001\/archinte.160.15.2402","relation":{},"ISSN":["0003-9926"],"issn-type":[{"type":"print","value":"0003-9926"}],"subject":[],"published":{"date-parts":[[2000,8,14]]}}}